Skip to content
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact
  • About
    • About EffRx
    • Business Strategy
    • Management Team
  • Therapeutic Areas
    • Osteoporosis
      • What is Osteoporosis
      • The Treatment Gap
      • The Adherence Gap
    • Rare Diseases
      • Rare Diseases in Europe
      • Orphan Medicines in Europe
      • Adrenal Insufficiency
      • Congenital Adrenal Hyperplasia
      • Niemann-Pick Disease Type C
  • Products & Pipeline
    • Binosto®
    • Alkindi®
    • Efmody®
    • Miglustat Dipharma
    • Pipeline Overview
  • Business Development
    • In-Licensing
    • Swiss & European Market Entry
    • World Orphan Drug Alliance (WODA)
    • Affiliations
  • Newsroom
    • News
    • Press Releases
  • Contact

PRODUCT INFORMATION

PATIENT INFORMATION

COMPENDIUM

PRODUCT INFORMATION / PATIENT INFORMATION

COMPENDIUM

PRODUCT INFORMATION / PATIENT INFORMATION

COMPENDIUM

PRODUCT INFORMATION / PATIENT INFORMATION

COMPENDIUM

PRODUCT INFORMATION

PATIENT INFORMATION

COMPENDIUM

Efmody®

PRODUCT INFORMATION / PATIENT INFORMATION

PRODUCT INFORMATION / PATIENT INFORMATION

COMPENDIUM

Product Information

Patient Information

Compendium

Product Information

Patient Information

Compendium

Product Information

Patient Information

Compendium

We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients
About Us
  • About EffRx
  • Business Strategy
  • Management Team
Business Development
  • In-licensing
  • European Market
  • World Orphan Drug Alliance
  • Affiliations
Legal
  • Privacy Policy

Copyright © 2024 All rights reserved

Web Design by Solvia

We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients
Linkedin
About Us
  • About EffRx
  • Business Strategy
  • Management Team
Business Development
  • In-licensing
  • European Market
  • World Orphan Drug Alliance
  • Affiliations
Legal
  • Privacy Policy

Copyright © 2024 All rights reserved

Web Design by Solvia

We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients

About Us

  • About EffRx
  • Business Strategy
  • Management Team

Business Development

  • In-licensing
  • European Market
  • World Orphan Drug Alliance
  • Affiliations

Legal

  • Privacy Policy

Copyright © 2024 All rights reserved

Web Design by Solvia